Teva argues that Eli Lilly induced infringement of two of Teva’s patents that protect the methods for administering the drug for the treatment of “refractory” migraines, or for patients who failed on at least two prior migraine preventative treatments.

       

CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.